Skip to main content
. 2007 Mar 14;13(10):1561–1568. doi: 10.3748/wjg.v13.i10.1561

Figure 5.

Figure 5

A: Western blot analysis of MEK1/2 and Akt phosphorylation in CXCL12-treated cholangiocarcinoma cells. RMCCA1 and KKU 100 were treated with 100 ng/mL of CXCL12 for indicated time. MEK1/2 and Akt phosphorylation were determined by Western blot as described; B: The average band intensity based on 3 biologically separate experiments, showing levels of MEK1/2 and Akt phosphorylation relative to the levels of MEK1/2 and Akt expression from the same experiment (aP < 0.05).